Evolve Medtech Partners

Evolve Medtech Partners is a medical device development company and discovery engine that collaborates with inventors, physicians, companies, and investors to efficiently advance ideas from conception through licensing, acquisition, or commercialization. Early-stage medical device companies are launched, co-located, and supported within the Evolve facility. The company provides leadership and expertise across every stage of product development, drawing on extensive experience and proven success to rapidly innovate and bring medical devices to market. Evolve and its extended partners offer deep capabilities in product development, intellectual property strategy, regulatory and quality, manufacturing, commercialization, clinical and business development. The company operates an ISO 13485:2016 and 21 CFR 820 compliant quality management system.

Evolve Medtech Partners offers a comprehensive suite of services to support the development and commercialization of medical devices. Their process includes idea generation, opportunity assessment, selection and formation, and growth and liquidity stages. The company operates an ISO 13485:2016 and 21 CFR 820 compliant quality management system, ensuring adherence to industry standards. Their facility includes a wet lab, R&D workspace, and advanced development equipment, located in Solana Beach, North County San Diego, at the heart of the region’s medical device ecosystem.

Evolve Medtech Partners has a diverse portfolio of medical device companies, including a breakthrough micro-catheter-based solution for treating chronic total occlusions (CTOs), a patented RF transseptal access system, a next-generation non-thermal cardiac ablation system, a pain-free, wireless, and battery-less medical device for the treatment of atrial fibrillation (Afib), single-use surgical retractor technology, endoscopic technology development structured as a build-to-buy with a strategic medical device company, over-the-wire transseptal access technology used in electrophysiology and structural heart procedures, and Vector Vascular, which is developing a catheter-based technology to assist in venous stenting procedures. These investments reflect Evolve Medtech Partners' commitment to advancing innovative medical technologies across various specialties.